Literature DB >> 27470453

Refining Stroke Prediction in Atrial Fibrillation Patients by Addition of African-American Ethnicity to CHA2DS2-VASc Score.

Rajesh Kabra1, Saket Girotra2, Mary Vaughan Sarrazin3.   

Abstract

BACKGROUND: Prior studies show that African-American patients have a higher risk of stroke compared with Caucasians.
OBJECTIVES: This study hypothesized addition of African-American ethnicity to CHA2DS2-VASc (congestive heart failure, hypertension, age ≥75 years, diabetes, previous stroke, vascular disease, age 65 to 74, and female sex) score might improve stroke prediction in patients with atrial fibrillation (AF).
METHODS: Medicare claims from January 2010 to December 2012 identified patients with newly diagnosed AF. The CHA2DS2-VASc was calculated on the basis of diagnoses in claims incurred during 12 months before first AF diagnosis. Ethnicity was identified from the Beneficiary Summary File. CHA2DS2-VASc-R score was calculated by giving 1 additional point for African-American ethnicity. The primary outcome was stroke, defined by primary diagnosis on acute inpatient admissions after the initial AF diagnosis. We used proportional hazards regression to determine the relationship between stroke and the CHA2DS2-VASc or a revised CHA2DS2-VASc-R score.
RESULTS: Of 460,417 patients with AF, 390,590 (85%) were non-Hispanic whites, 31,702 (7%) were non-Hispanic African Americans, and the remainder were other non-white ethnicities. Mean age was 79.2 ± 8.0 years, with 60% females. Overall, 16,703 stroke events occurred, and 151,441 (32.7%) patients died during a mean follow-up period of 18.0 months. Compared with CHA2DS2-VASc, CHA2DS2-VASc-R score improved the fit of the model significantly as measured by the log likelihood ratio statistic (p < 0.001). Among individual risk factors in CHA2DS2-VASc-R score, only prior stroke, age ≥75 years, and female sex had a stronger association with incident stroke than African-American ethnicity.
CONCLUSIONS: In patients >65 years of age with newly diagnosed AF, the addition of ethnicity to CHA2DS2-VASc score significantly improved stroke prediction.
Copyright © 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  atrial fibrillation; ethnicity; risk score; stroke

Mesh:

Year:  2016        PMID: 27470453      PMCID: PMC5394427          DOI: 10.1016/j.jacc.2016.05.044

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  33 in total

1.  European ancestry as a risk factor for atrial fibrillation in African Americans.

Authors:  Gregory M Marcus; Alvaro Alonso; Carmen A Peralta; Guillaume Lettre; Eric Vittinghoff; Steven A Lubitz; Ervin R Fox; Yamini S Levitzky; Reena Mehra; Kathleen F Kerr; Rajat Deo; Nona Sotoodehnia; Meggie Akylbekova; Patrick T Ellinor; Dina N Paltoo; Elsayed Z Soliman; Emelia J Benjamin; Susan R Heckbert
Journal:  Circulation       Date:  2010-11-16       Impact factor: 29.690

2.  Choices in the use of ICD-9 codes to identify stroke risk factors can affect the apparent population-level risk factor prevalence and distribution of CHADS2 scores.

Authors:  James A Rothendler; Adam J Rose; Joel I Reisman; Dan R Berlowitz; Lewis E Kazis
Journal:  Am J Cardiovasc Dis       Date:  2012-07-25

3.  Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets.

Authors:  Prabasaj Paul; Michael L Pennell; Stanley Lemeshow
Journal:  Stat Med       Date:  2012-07-26       Impact factor: 2.373

Review 4.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

5.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

6.  Adverse outcomes and predictors of underuse of antithrombotic therapy in medicare beneficiaries with chronic atrial fibrillation.

Authors:  B F Gage; M Boechler; A L Doggette; G Fortune; G C Flaker; M W Rich; M J Radford
Journal:  Stroke       Date:  2000-04       Impact factor: 7.914

Review 7.  Statistical methods for assessment of added usefulness of new biomarkers.

Authors:  Michael J Pencina; Ralph B D'Agostino; Ramachandran S Vasan
Journal:  Clin Chem Lab Med       Date:  2010-08-18       Impact factor: 3.694

8.  Prevalence of and Racial Disparities in Risk Factor Control in Older Adults With Diabetes: The Atherosclerosis Risk in Communities Study.

Authors:  Christina M Parrinello; Ina Rastegar; Job G Godino; Michael D Miedema; Kunihiro Matsushita; Elizabeth Selvin
Journal:  Diabetes Care       Date:  2015-04-07       Impact factor: 19.112

9.  CHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis.

Authors:  Jia-Yuan Chen; Ai-Dong Zhang; Hong-Yan Lu; Jun Guo; Fei-Fei Wang; Zi-Cheng Li
Journal:  J Geriatr Cardiol       Date:  2013-09       Impact factor: 3.327

10.  Atrial fibrillation, stroke, and anticoagulation in Medicare beneficiaries: trends by age, sex, and race, 1992-2010.

Authors:  Gautam R Shroff; Craig A Solid; Charles A Herzog
Journal:  J Am Heart Assoc       Date:  2014-06-03       Impact factor: 5.501

View more
  14 in total

1.  Impact of race and gender on clinical outcomes of catheter ablation in patients with atrial fibrillation.

Authors:  Abdallah Bukari; Hemal Nayak; Zaid Aziz; Amrish Deshmukh; Roderick Tung; Cevher Ozcan
Journal:  Pacing Clin Electrophysiol       Date:  2017-09-20       Impact factor: 1.976

Review 2.  Incorporating Stroke and Bleeding Risk Stratification Tools into Atrial Fibrillation Management Making Sense of the Alphabet Soup.

Authors:  Thomas F Deering
Journal:  J Atr Fibrillation       Date:  2017-04-30

Review 3.  Stroke Risk in Atrial Fibrillation: Beyond the CHA2DS2-VASc Score.

Authors:  Pooja S Jagadish; Rajesh Kabra
Journal:  Curr Cardiol Rep       Date:  2019-07-27       Impact factor: 2.931

4.  Prescribing of anticoagulation for atrial fibrillation in primary care.

Authors:  Kathryn A Martinez; Mark H Eckman; Matthew A Pappas; Michael B Rothberg
Journal:  J Thromb Thrombolysis       Date:  2022-04-21       Impact factor: 2.300

5.  Race and stroke in an atrial fibrillation inception cohort: Findings from the Penn Atrial Fibrillation Free study.

Authors:  Parin J Patel; Ronit Katz; Yuliya Borovskiy; Anthony Killian; Joshua M Levine; Nelson W McNaughton; David Callans; Gregory Supple; Sanjay Dixit; Andrew E Epstein; Francis E Marchlinski; Rajat Deo
Journal:  Heart Rhythm       Date:  2018-02-20       Impact factor: 6.343

6.  Race and Stroke Risk in Atrial Fibrillation: The Limitations of a Social Construct.

Authors:  Amber E Johnson; Jared W Magnani
Journal:  J Am Coll Cardiol       Date:  2017-02-21       Impact factor: 24.094

7.  Racial Disparities in In-Hospital Adverse Events Among Patients With Atrial Fibrillation Implanted With a Watchman Left Atrial Appendage Occlusion Device: A US National Perspective.

Authors:  Muhammad Zia Khan; Muhammad Bilal Munir; Douglas Darden; Deepak Kumar Pasupula; Sudarshan Balla; Frederick T Han; Ryan Reeves; Jonathan C Hsu
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-04-28

8.  Incidence of Atrial Fibrillation in African Americans post Atrial Flutter Ablation.

Authors:  Robert L Percell; Robert Helm; Kevin Monahan
Journal:  J Atr Fibrillation       Date:  2020-02-28

Review 9.  Social determinants of atrial fibrillation.

Authors:  Utibe R Essien; Jelena Kornej; Amber E Johnson; Lucy B Schulson; Emelia J Benjamin; Jared W Magnani
Journal:  Nat Rev Cardiol       Date:  2021-06-02       Impact factor: 32.419

Review 10.  A Review of Biomarkers for Ischemic Stroke Evaluation in Patients With Non-valvular Atrial Fibrillation.

Authors:  Luxiang Shang; Ling Zhang; Yankai Guo; Huaxin Sun; Xiaoxue Zhang; Yakun Bo; Xianhui Zhou; Baopeng Tang
Journal:  Front Cardiovasc Med       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.